Multiple teams focused on AI-driven protein design are pushing toward explainability and safer deployment, with research highlighting how current protein language-model workflows can be made more transparent. The work centers on mechanisms that connect model outputs to design rationale, aiming to reduce uncertainty when AI-generated candidates move toward experimental validation. At the same time, new frameworks for safer and more transparent protein-design AI are being positioned as an operational requirement for scaling discovery, especially where regulatory-grade documentation and reproducibility matter. The editorial thrust is that interpretability must keep pace with model capability. For drug developers, improved explainability can shorten feedback loops between design iteration and wet-lab testing by clarifying which sequence or structural features are driving binding or function.